This is an interdisciplinary program designed for graduates with backgrounds in either pharmacology or biotechnology who wish to obtain advanced training in both areas in order to gain expertise necessary for the development and use of the new generation of biopharmaceuticals which have been developed by, or result from, the application of molecular biology. It is open to graduates with a four-year degree in a related discipline or who have, in the opinion of the Higher Degree Committee, acquired equivalent qualifications or experience. Prior study of biochemistry is required for the program. The program teaches the scientific bases underscoring the development of recombinant biopharmaceuticals, combined with aspects of clinical trials and regulatory considerations. The program content is incorporated in courses comprised of written text containing program materials, demonstrations, laboratory experiments and self-testing exercises.

The Master's program calls for the completion of eight courses, for a total of 48 UOC. 36UOC is obtained from coursework and the remaining 12UOC is obtained from two research projects.

The program is run over two 14-week sessions and can be completed in one year full-time or two years part-time.

Please contact the School of Biotechnology and Biomolecular Sciences Student Office for information.

Plus two of:

Plus one of:

Please refer to the Program Structure above or contact the school office for further information.

For information regarding fees for UNSW programs, please refer to the following website:  https://my.unsw.edu.au/student/fees/FeesMainPage.html